Related Experiment Video
Updated: Nov 1, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based Review
In Silico Trials use computer simulations for medical product evaluation. Experts identified 46 potential Contexts of Use (CoUs) for these predictive models, organizing them into nine categories to guide regulatory science development.
Area of Science:
- Computational medicine
- Regulatory science
- Medical product development
Background:
- In Silico Trials leverage computer modeling and simulation to assess medical product safety and efficacy.
- Predictive models are emerging as novel methodologies for both the development and regulatory assessment of medical products.
- Regulatory bodies like the FDA and EMA qualify new methodologies through formal processes, starting with defining the Context of Use (CoU).
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
In Vitro Drug Release Testing: Overview, Development and Validation
Clinical Trials: Overview
Equivalence: In Vitro and In Vivo Bioequivalence
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview